Oestrogen receptor pathway activity is associated with outcome in endometrial cancer.

Willem Jan van WeeldenLouis J M van der PuttenMárcia A IndaAnne van BrusselMarc P L M SnijdersLisanne M M SchrieverJohan BultenLeon F A G MassugerAnja van de StolpeJohanna M A Pijnenborg

Published in: British journal of cancer (2020)

The ER pathway test reflects activity of the ER pathway, and may improve prediction of outcome in EC patients.

Keyphrases

endometrial cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
breast cancer cells